In a closed-loop control approach to managing type 1 diabetes, glucose sensors placed under the skin continuously monitor blood sugar levels, triggering the release of insulin from an implantable insulin pump as needed.
The aim of this closed-loop insulin delivery system is improved control of blood glucose levels throughout the day and night. But a new study in adults and adolescents found that mean blood glucose levels remained at safe levels 53-82% of the time, according to the results published in Diabetes Technology&Therapeutics.
Howard Zisser, MD and an international team of researchers representing the Control to Range Study Group measured plasma glucose levels every 15-30 minutes in a group of individuals with type 1 diabetes who participated in the "Control to Range" multinational artificial pancreas study. They monitored the adults and teens over 22 hours, including three meals and periods of day and night.
The authors describe the risks of hypo- and hyperglycemia, the variability between participants, and the differences in daytime/nighttime results, and also propose improvements needed in the design and implementation of closed-loop systems in the article "Multicenter Closed-Loop Insulin Delivery Study Points to Challenges for Keeping Blood Glucose in a Safe Range by a Control Algorithm in Adults and Adolescents with Type 1 Diabetes from Various Sites".
"It appears that we are getting closer to an Artificial Pancreas option for patients with type 1 diabetes," says DTT Editor-in-Chief Satish Garg, MD, Professor of Medicine and Pediatrics at the University of Colorado Denver. "The first version may need to be a hybrid system in which meals and exercise are announced with necessary dose adjustments along with Automatic Threshold Suspend for hypoglycemia."
Citation: Zisser H, Renard E, Kovatchev B, Cobelli C, Avogaro A, Nimri R, Magni L, Buckingham BA, Chase HP, Doyle FJ, Lum J, 'Multicenter Closed-Loop Insulin Delivery Study Points to Challenges for Keeping Blood Glucose in a Safe Range by a Control Algorithm in Adults and Adolescents with Type 1 Diabetes from Various Sites', Diabetes Technology & Therapeutics doi:10.1089/dia.2014.0066.
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Part I: Bee Deaths Mystery Solved? Neonicotinoids (Neonics) May Actually Help Bee Health
- 3X Saturated Fat In The Diet Doesn't Increase It In Blood
- Eosinophilic Esophagitis: Genetic Clues Of Severe Food Allergy
- Still No Contact with NASA's Sun-watching Probe
- Interstellar Is A Dangerous Fantasy Of US Colonialism
- Want A Man To Help? High Heels Work
- Is Religion A Consolation Worth Having?
- "As an earlier cigarette smoker and now e-cig smoker, I can confirm they don't help you quit. As..."
- "Reality? What is reality if you use irrational arguments to justify man's cruelty toward..."
- "Always loved the Heels that showed of the instep (arches) ..."
- "By the way, I am a fan of your blog. It's one of the few places I can follow physics without getting..."
- "Hello Anon,you're entirely right, it's arbitrary and it does not provide protection against cases..."
- Gene in kidney may play role in high blood pressure
- Panel-based genetic diagnostic testing for inherited eye disease proves highly accurate
- Research finds tooth enamel fast-track in humans
- Good news for cocaine users: Caffeine counters cocaine's effects on women's estrus cycles
- Clipping proteins that package genes may limit abnormal cell growth in tumors